ICER's mission is to lead innovation in comparative effectiveness research through methods that integrate considerations of clinical benefit and economic value. Through a unique collaboration with patients, clinicians, manufacturers, insurers and other healthcare stakeholders, ICER develops tools to support patient decisions and medical policy that share the goal of achieving maximum value for every healthcare dollar.
| ICER's Chief Review Officer quoted in Pink Sheet story on comparative effectiveness research |
|
Cost Quietly Remains The 800-Pound Gorilla In The CER Room
In the run-up to passage of the Patient Protection and Affordable Care Act, there was much debate on the subject of cost effectiveness in the context of comparative effectiveness research, with legislators carefully wording CER provisions to keep cost effectiveness at bay. But the concept of cost in comparative effectiveness research remains a hurdle that can impede CER's forward momentum if it is not addressed. Read more from the May 24 Pink Sheet story. |